PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
April 12, 2024European Respiratory Journal

The carbon footprint of as-needed budesonide/formoterol in mild asthma: apost hocanalysis

View Full Paper
Ask AI
Bookmark
Share

Authors

LHLee HatterMHMark HollidayAEAllie Eathorne

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hatter et al. (2024) studied this question.

synapsesocial.com/papers/68e6f5edb6db64358767002ehttps://doi.org/10.1183/13993003.01705-2023
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A breath of fresh AIR: reducing the carbon footprint of asthma2022 · 10 citations
  2. 2Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers2020 · 21 citations
  3. 3Carbon footprint impact of the choice of inhalers for asthma and COPD2019 · 247 citations
  4. 4Real-World Impact of Nonclinical Inhaler Regimen Switches on Asthma or COPD: A Systematic Review2022 · 34 citations
  5. 5Exacerbation risk and characterisation of the UK’s asthma population from infants to old age2017 · 162 citations